Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,850.00
-200.00 (-1.99%)
Jun 27, 2025, 3:30 PM KST

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 225.60 billion as of June 27, 2025. Its market cap has decreased by -48.50% in one year.

Market Cap
225.60B
Enterprise Value
187.55B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,850.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 225.60B, an increase of 40.79%. That is a compound annual growth rate of 7.48%.

History

DateMarket Cap% Change
Jun 18, 2025225.60B-5.93%
Dec 30, 2024239.82B-53.54%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 20202,517.20B1,470.89%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Electronics 391.17T
SK hynix 196.06T
Samsung Biologics 71.46T
LG Energy Solution 67.39T
Hyundai Motor Company 45.04T
Doosan Enerbility 42.14T
Hanwha Aerospace 41.99T
Kia Corporation 38.55T
Market Cap Rankings